Skip to main content

and
  1. Article

    Open Access

    Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation

    The oral and gastrointestinal mucosae represent the main targets of the toxic effect of chemo and/or radiotherapy administered during the conditioning regimen before hematopoietic stem cell transplant (HSCT). ...

    M. Faraci, C. Bonaretti, G. Dell’Orso, F. Pierri, S. Giardino in Scientific Reports (2024)

  2. Article

    Open Access

    Targeting GD2 after allogeneic SCT: effector cell composition defines the optimal use of ch14.18 and the bispecific antibody construct NG-CU (GD2-CD3)

    We investigated whether T cell-recruiting bispecific anti-CD3/GD2 antibody NG-CU might be an alternative to therapeutic anti-GD2 monoclonal antibody (mAb) ch14.18, mediating complement-dependent cytotoxicity (...

    A.-M. Arendt, F. Heubach, C. P. Maier, S. Giardino in Cancer Immunology, Immunotherapy (2023)

  3. No Access

    Article

    Successful management of cutaneous BCG dissemination in a child affected by SCID and receiving allogeneic hematopoietic stem cell transplant

    A Naselli, G Losurdo, S Giardino, G Morreale, C Savioli in Bone Marrow Transplantation (2015)

  4. No Access

    Article

    Bacteremias and invasive fungal diseases in children receiving etanercept for steroid-resistant acute GVHD

    M Faraci, E Lanino, G Morreale, S Giardino, M Fossati in Bone Marrow Transplantation (2011)

  5. No Access

    Article

    Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children

    EBV-associated post transplant lymphoproliferative disease (EBV-PTLD) is a life-threatening complication that may occur after hemopoietic SCT. We prospectively screened 80 children on a weekly basis using nest...

    M Faraci, I Caviglia, G Morreale, E Lanino, D Cuzzubbo in Bone Marrow Transplantation (2010)

  6. No Access

    Article

    Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience

    GVHD remains a serious complication after allogeneic SCT. We describe 13 paediatric patients treated with daclizumab for refractory acute GVHD (aGVHD). After 30 days of daclizumab administration, all patients ...

    M Miano, D Cuzzubbo, P Terranova, S Giardino, E Lanino in Bone Marrow Transplantation (2009)

  7. No Access

    Article

    Strategies of the donor search for children with second CR ALL lacking a matched sibling donor

    During the last 10 years, the number of alternative Haematopoietic stem cell transplantations (HSCTs) performed on children in Europe has increased significantly and has reached 61% of the allografts. In this ...

    E Lanino, N Sacchi, C Peters, S Giardino, V Rocha, G Dini in Bone Marrow Transplantation (2008)